Artelo Biosciences (ARTL) Interest Expenses (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Interest Expenses of -$26000.0 for Q4 2025, down 100.46% year-over-year from $5.7 million in Q4 2024, and down 123.42% quarter-over-quarter from $111000.0 in Q3 2025.
Artelo Biosciences (ARTL) Interest Expenses (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Interest Expenses for 11 consecutive years, with -$26000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Expenses fell 100.46% year-over-year to -$26000.0; the TTM figure through Dec 2025 stood at $93000.0 (down 98.36% YoY), while the FY2025 annual figure was $7.8 million, up 37.67% from the prior year.
- Interest Expenses retreated to -$26000.0 in Q4 2025 per ARTL's latest filing, from $111000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $5.7 million in Q4 2024 and bottomed at -$26000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $393044.7 across 5 years, with a median of $23000.0 in 2022.
- On a YoY basis, Interest Expenses climbed as much as 2530.0% in 2025 and fell as far as 100.46% in 2025.
- Artelo Biosciences' Interest Expenses stood at $76380.0 in 2021, then tumbled by 106.55% to -$5000.0 in 2022, then soared by 740.0% to $32000.0 in 2023, then soared by 17643.75% to $5.7 million in 2024, then sank by 100.46% to -$26000.0 in 2025.
- Business Quant data shows ARTL's Interest Expenses at -$26000.0 in Q4 2025, $111000.0 in Q3 2025, and $526000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26,000.00 |
| Dec 31, 2025 | -26,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 526,000.00 |
| Jun 30, 2025 | 526,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 5.68 Mn |
| Dec 31, 2024 | 5.68 Mn |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 24,000.00 |